These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22195314)

  • 1. New method uses biomarkers to discriminate cancer cells present in bodily fluids.
    Lake F
    Expert Rev Proteomics; 2011 Dec; 8(6):687. PubMed ID: 22195314
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane vesicles in ovarian cancer fluids: a new potential marker.
    Ginestra A; Miceli D; Dolo V; Romano FM; Vittorelli ML
    Anticancer Res; 1999; 19(4C):3439-45. PubMed ID: 10629632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovering circulating extracellular or cell-free RNA from bodily fluids.
    Tzimagiorgis G; Michailidou EZ; Kritis A; Markopoulos AK; Kouidou S
    Cancer Epidemiol; 2011 Dec; 35(6):580-9. PubMed ID: 21514265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based "omics" technologies in cancer diagnostics.
    Zhang X; Wei D; Yap Y; Li L; Guo S; Chen F
    Mass Spectrom Rev; 2007; 26(3):403-31. PubMed ID: 17405143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
    Lee KD; Lee HS; Jeon CH
    Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic tests for molecular markers of cancer].
    Miyachi H; Asai S
    Rinsho Byori; 2003 Dec; 51(12):1195-202. PubMed ID: 14743743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor associated biomarker for early diagnosis of cancer].
    Ohkura H
    Nihon Rinsho; 1996 May; 54(5):1281-5. PubMed ID: 8965352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers; a review].
    Bosman FT
    Ned Tijdschr Geneeskd; 1987 Nov; 131(45):2016-21. PubMed ID: 3317077
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers of Alzheimer's disease in body fluids.
    Zheng Y; He J; Hong T
    Sci China Life Sci; 2010 Apr; 53(4):490-6. PubMed ID: 20596916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-associated trypsin inhibitor and tumour-associated trypsin.
    Stenman UH
    Scand J Clin Lab Invest Suppl; 1990; 201():93-101. PubMed ID: 2244188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation.
    Hood BL; Stewart NA; Conrads TP
    Clin Lab Med; 2009 Mar; 29(1):115-38. PubMed ID: 19389555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
    Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
    Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated DNA as a possible screening marker for neoplastic disease in several body fluids.
    Müller HM; Widschwendter M
    Expert Rev Mol Diagn; 2003 Jul; 3(4):443-58. PubMed ID: 12877384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
    Gazdar AF; Mulshine JL; Kramer BS
    Immunol Ser; 1990; 53():453-68. PubMed ID: 1966068
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
    Kischel P; Waltregny D; Castronovo V
    Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A need for basic research on fluid-based early detection biomarkers.
    Martin KJ; Fournier MV; Reddy GP; Pardee AB
    Cancer Res; 2010 Jul; 70(13):5203-6. PubMed ID: 20587531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General aspects and cytology of body cavity fluids].
    Kurita S
    Rinsho Byori; 1990 Nov; Suppl 87():41-68. PubMed ID: 2287090
    [No Abstract]   [Full Text] [Related]  

  • 19. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
    Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
    Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of electrophoresis in disease biomarker discovery.
    Issaq HJ; Veenstra TD
    Electrophoresis; 2007 Jun; 28(12):1980-8. PubMed ID: 17503404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.